Translational Research in Stem Cell Treatment of Neuromuscular Diseases

Table 5

Table summarizing the preclinical studies on the treatment of muscular dystrophies with stem cells.

Stem cell	References
Mouse BMCs (as a vehicle for gene delivery)	[34, 35]
Mouse BMCs	[39, 125–128]
Mouse HSCs	[40]
Dog HSCs	[129]
Human HSCs	[130]
Human BMCs	[131, 132]
Mouse MDSCs (as a vehicle for gene delivery)	[36]
Mouse MDSCs	[133–135]
Dog MDSCs	[136]
Human MDSCs	[137, 138]
Mouse mesoangioblasts (as a vehicle for gene delivery)	[5]
Mouse mesoangioblasts	[139–142]
Canine mesoangioblasts	[143]
Mouse iPS	[144–146]
Human ASCs	[147–152]
Mouse myoblasts/MPCs	[135, 153–165]
Dog myoblast/MPCs	[166]
Porcine myoblast/MPCs	[167]
Monkey myoblasts/MPCs	[33]
Human myoblast/MPCs	[168–172]
Human UCBCs	[148, 173, 174]
Human SSCs*	[175, 176]
Mouse ESCs	[177, 178]
Mouse ESC-derived myogenic precursors	[179]
Mouse BMC-derived myogenic precursors	[32, 180]
Mouse satellite cells	[38]
Human primordial germ cells	[181]
Human IDPSC**	[182]
Human primary fetal skeletal muscle cells	[183]
hfMSCs***	[184, 185]
BM transplantation (in mice)	[186]
Mouse side population cells (as a vehicle for gene delivery)	[37]

*Synovial stem cells, **human immature dental pulp stem cells, ***human fetal mesenchymal stem cells.